Viking Therapeutics (1VKTX.MI) Q1 2026 Earnings

Feb 11Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.16
-0.87
-0.58
-0.29

Details

Expected EPS
-0.74965666752
Actual EPS
-1.1620704
Surprise EPS
-0.41
Surprise Percent
-55.01%

Description

⁨Viking Therapeutics⁩ (⁦1VKTX.MI⁩) has reported earnings of ⁦-1.1620704⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts